Additive Manufacturing Is Now Approved For Prosthetic Coding And Reimbursement
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Additive Manufacturing Is Now Approved For Prosthetic Coding And Reimbursement
-
ナレーター：
-
著者：
このコンテンツについて
Send us a text
Two sentences from PDAC can potentially change the course of manufacturing history for O & P: additive manufacturing is now explicitly acceptable for coding prosthetic devices that meet existing HCPCS descriptions. We unpack what that clarity means for clinicians, patients, vendors, and payers, and how to adopt 3D printing without tripping on compliance.
• Why PDAC’s language ends the gray area for 3D‑printed prosthetics
• What PDAC and DME MAC do and how they shape coding
• How to match additive devices to existing L code descriptions
• Documentation discipline to avoid denials and audits
• FDA’s proactive stance and signals to industry
• Medicare vs Medicare Advantage realities for reimbursement
• When new codes help vs when they stall at zero pay
• Scaling care amid workforce shortages using digital workflows
• Using additive to improve fit, speed, and repeatability
• Practical steps to start: scanning, CAD, materials, records
Special thanks to Advanced 3D for sponsoring this episode.
Support the show